The Yale-Brown Obsessive Compulsive Scale \u2013 Self-Report (Y-BOCS-SR)<\/strong> represents the self-administered adaptation of the clinician-rated Yale-Brown Obsessive Compulsive Scale (Y-BOCS)<\/a>, widely recognized across clinical psychiatry and behavioral neuroscience as the gold-standard instrument for quantifying the severity of obsessive-compulsive disorder (OCD)<\/a> symptoms. Designed to measure symptom magnitude independently of the specific thematic content of a patient’s obsessions or compulsions, the scale operationalizes obsessive-compulsive severity across five core phenotypic dimensions: time occupied, functional interference, subjective distress, active resistance, and degree of control. The instrument comprises 10 primary severity items split evenly into two five-item subscales: the Obsessions Severity Subscale<\/em> (Items 1\u20135) and the Compulsions Severity Subscale<\/em> (Items 6\u201310).<\/p>\n Each item is rated on a 5-point Likert scale<\/a> ranging from 0 (no symptoms\/complete control) to 4 (extreme symptoms\/complete lack of control), generating a composite global score from 0 to 40, alongside domain-specific subscale totals ranging from 0 to 20. Extensive psychometric evaluations demonstrate high internal consistency across diverse clinical cohorts, with Cronbach’s alpha<\/a> typically ranging between .86 and .93 for the total score, and test-retest reliability coefficients exceeding .85 across intervals ranging from one to two weeks. Convergent validity with clinician-rated Y-BOCS interviews is exceptionally strong (Pearson’s r<\/em> = .78 to .91), indicating that the self-report modality captures symptom burden with fidelity comparable to expert clinical assessment while drastically minimizing administrative burden in large-scale psychopharmacological trials, epidemiologic investigations, and routine psychiatric outcome monitoring<\/span>.<\/p>\n Yale-Brown Obsessive Compulsive Scale, Y-BOCS-SR, Obsessive-Compulsive Disorder, Psychometrics, Self-Report, Severity Measurement, Exposure and Response Prevention, Obsessions, Compulsions, Clinical Assessment<\/p>\n The original clinician-administered Yale-Brown Obsessive Compulsive Scale was developed by an interdisciplinary team of clinical psychiatrists and neuropsychopharmacologists at Yale University School of Medicine and Brown University:<\/p>\n The self-report adaptation (Y-BOCS-SR) was subsequently validated and refined through prominent psychometric studies spearheaded by Lee Baer, Ph.D.<\/strong>, Gail Steketee, Ph.D.<\/strong>, and Michael A. Jenike, M.D.<\/strong> at Massachusetts General Hospital and Boston University, confirming the empirical equivalence and structural fidelity of the paper-and-pencil and electronic self-report formats compared to the semi-structured clinician interview.<\/p>\n The primary clinical and psychometric objective of the Y-BOCS-SR is to provide a standardized, structurally robust, and time-efficient self-report instrument capable of evaluating obsessive-compulsive symptom severity across psychiatric and research settings. Prior to the introduction of the Y-BOCS framework, clinical measurement of OCD suffered from a fundamental methodological confounding: instruments routinely conflated the breadth or qualitative content<\/em> of symptoms (e.g., number of specific washing, checking, or counting rituals) with the dimensional severity<\/em> (e.g., functional impairment and distress) of the illness. Consequently, an individual with a single, disabling checking compulsion occupying ten hours daily might have scored lower on older inventories than an individual with five mild, non-impairing idiosyncrasies. The Y-BOCS-SR circumvents this limitation by dissociating symptom manifestation from severity grading, standardizing the evaluation of obsessive-compulsive phenomena across universal dimensional indices.<\/p>\n In clinical practice, the Y-BOCS-SR serves as an indispensable tool across the continuum of care:<\/p>\n The Y-BOCS-SR operationalizes obsessive-compulsive disorder as a multi-dimensional construct defined by the interaction between recurrent, intrusive mental events (obsessions<\/a>) and repetitive behavioral or mental rituals executed to neutralize distress or prevent feared outcomes (compulsions<\/a>). Rather than assessing these phenomena globally, the scale dissects obsessions and compulsions across five distinct phenomenological dimensions, generating a granular psychometric profile:<\/p>\n The architectural configuration of the Y-BOCS-SR is grounded in the convergence of cognitive-behavioral theory, neurobiological circuit models, and empirical psychopathology:<\/p>\n The instrument is anchored in the cognitive-behavioral formulation of OCD articulated by Paul Salkovskis<\/a> and Jack Rachman<\/a>. Within this model, intrusive thoughts, images, and impulses are ubiquitous phenomenological occurrences across the general population. Pathological obsessions arise not from the intrusions themselves, but from the dysfunctional, catastrophic appraisals attributed to them (e.g., inflated responsibility, thought-action fusion, overestimation of threat, and intolerance of uncertainty). Compulsions emerge as maladaptive behavioral or cognitive neutralization strategies intended to alleviate the distress triggered by catastrophic misinterpretations. The Y-BOCS-SR captures this functional cycle by measuring the direct affective distress elicited by intrusions (Item 3), the behavioral drive to perform compulsions to avert distress (Item 8), and the secondary functional interference resulting from these self-perpetuating neutralization loops (Items 2 and 7).<\/p>\n From a neurobiological standpoint, the dimensions indexed by the Y-BOCS-SR reflect dysregulation within frontostriatal networks, specifically the cortico-striato-thalamo-cortical (CSTC) loop<\/a> involving the orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), and striatum (caudate nucleus). In neuroimaging investigations, elevated scores on the Y-BOCS Time and Resistance items strongly correlate with hyperactivation in the OFC and ventral striatum during error detection and symptom provocation tasks. Structural and functional alterations within the dorsolateral prefrontal cortex (dlPFC) correspond directly with compromised performance on Item 5 (Control Over Obsessions) and Item 10 (Control Over Compulsions), reflecting impairments in top-down inhibitory control and cognitive flexibility.<\/p>\n The validity of the Y-BOCS-SR has been empirically established across diverse clinical, non-clinical, and cross-cultural cohorts:<\/p>\n Convergent validity is documented through robust correlations with the clinician-administered Y-BOCS interview. Studies by Steketee et al. (1996), Baer et al. (1993), and Rosenfeld et al. (1992) reported correlation coefficients between self-report total scores and clinician-derived scores ranging from r<\/em> = .78 to r<\/em> = .91 across treatment-seeking samples. Strong convergent associations are consistently observed with alternative OCD assessment batteries, including the Obsessive-Compulsive Inventory-Revised (OCI-R)<\/em> (r<\/em> = .68 to .77) and the Padua Inventory-Washington State University Revision (PI-WSUR)<\/em> (r<\/em> = .62 to .74)<\/span>.<\/p>\n The scale demonstrates acceptable discriminant validity when contrasted against generalized affective and neurotic constructs. Although moderate correlations exist between the Y-BOCS-SR total score and measures of generalized depression and anxiety\u2014such as the Beck Depression Inventory-II (BDI-II)<\/a> (r<\/em> = .40 to .55) and the Beck Anxiety Inventory (BAI)<\/em> (r<\/em> = .42 to .58)\u2014these relationships reflect the known high comorbidity between OCD, major depressive disorder, and secondary anxiety states. When controlling for general negative affect, the Y-BOCS-SR retains its ability to differentiate OCD cohorts from individuals with panic disorder, generalized anxiety disorder, and healthy controls (p<\/em> < .001)<\/span>.<\/p>\n The Y-BOCS-SR exhibits high sensitivity to therapeutic change. Randomized controlled trials evaluating pharmacological agents (such as fluoxetine, sertraline, and fluvoxamine) and behavioral protocols (such as manualized ERP) demonstrate that reductions in Y-BOCS-SR scores parallel clinician ratings throughout double-blind treatment phases (Cohen’s d<\/em> effect sizes ranging from 0.95 to 1.62). The instrument reliably identifies post-intervention functional status, with reductions in subscale scores predicting long-term relapse prevention and quality of life restoration.<\/p>\n The psychometric reliability of the Y-BOCS-SR has been corroborated across numerous clinical trials and normative psychometric validations:<\/p>\n The scale consistently exhibits strong internal consistency across clinical settings:<\/p>\n Temporal stability evaluations demonstrate substantial consistency when reassessed during periods of symptom stability:<\/p>\n Structural investigations of the Y-BOCS and Y-BOCS-SR using exploratory factor analysis (EFA)<\/a> and confirmatory factor analysis (CFA)<\/a> have clarified the underlying dimensionality of the 10-item scale:<\/p>\n The theoretically hypothesized structure posits a two-factor latent model aligning with the clinical division of symptoms:<\/p>\n While this model exhibits acceptable fit in several initial psychometric trials, empirical CFA evaluations frequently indicate elevated residual covariance between parallel items (e.g., Item 1 [Obsession Time] and Item 6 [Compulsion Time]; Item 4 [Obsession Resistance] and Item 9 [Compulsion Resistance]).<\/p>\n Subsequent structural equation modeling investigations across large clinical cohorts (e.g., McKay et al., Storch et al., Amir et al.) identified an alternative three-factor configuration that often yields superior fit indices:<\/p>\n Fit parameters for this three-factor framework and corresponding bifactor models demonstrate good alignment with contemporary psychometric benchmarks: Comparative Fit Index (CFI) > .95, Tucker-Lewis Index (TLI) > .94, Root Mean Square Error of Approximation (RMSEA) ≤ .055 (90% CI: .041\u2013.068), and Standardized Root Mean Square Residual (SRMR) ≤ .045<\/span>.<\/p>\n The clinician-administered Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was originally published in 1989 by Wayne K. Goodman, Lawrence H. Price, Steven A. Rasmussen, and colleagues in the Archives of General Psychiatry<\/em>. The self-report version (Y-BOCS-SR) was developed and validated in the early 1990s through collaborative research teams led by Lee Baer, Gail Steketee, and colleagues.<\/p>\n The 10-item severity scale is widely treated within the global scientific, academic, and clinical research communities as an accessible clinical assessment tool for non-profit research, academic investigation, and individual clinical practice. However, commercial utilization\u2014including integration into proprietary corporate digital health applications, commercial clinical trials sponsored by pharmaceutical corporations, or distribution within fee-for-service enterprise medical record ecosystems\u2014may require formal permission, translation certification, or licensing agreements from the intellectual property holders or copyright-retaining institutions. Researchers and institutional clinicians should verify institutional policy prior to large-scale deployment.<\/p>\n Amir, N., Foa, E. B., & Coles, M. E. (1997). Factor structure of the Yale-Brown Obsessive Compulsive Scale. Psychological Assessment<\/em>, 9(1), 44\u201348. https:\/\/doi.org\/10.1037\/1040-3590.9.1.44<\/a><\/p>\n Baer, L., Brown-Beasley, M. W., Sorce, J., & Henriques, A. I. (1993). Computer-assisted telephone administration of a structured interview for obsessive-compulsive disorder. The American Journal of Psychiatry<\/em>, 150(11), 1737\u20131738. https:\/\/doi.org\/10.1176\/ajp.150.11.1737<\/a><\/p>\n Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., & Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale: II. Validity. Archives of General Psychiatry<\/em>, 46(11), 1012\u20131016. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810110054008<\/a><\/p>\n Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., Heninger, G. R., & Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry<\/em>, 46(11), 1006\u20131011. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810110048007<\/a><\/p>\n McKay, D., Danyko, S. J., Neziroglu, F., & Yaryura-Tobias, J. A. (1995). Factor structure of the Yale-Brown Obsessive-Compulsive Scale: A critical review. Depression and Anxiety<\/em>, 2(3), 115\u2013123. https:\/\/doi.org\/10.1002\/da.10002<\/a><\/p>\n Rosenfeld, R., Dar, R., Anderson, D., Kobak, K. A., & Greist, J. H. (1992). A computer-administered version of the Yale-Brown Obsessive-Compulsive Scale. Psychological Assessment<\/em>, 4(3), 329\u2013332. https:\/\/doi.org\/10.1037\/1040-3590.4.3.329<\/a><\/p>\n Salkovskis, P. M. (1985). Obsessional-compulsive problems: A cognitive-behavioural analysis. Behaviour Research and Therapy<\/em>, 23(5), 571\u2013583. https:\/\/doi.org\/10.1016\/0005-7967(85)90105-6<\/a><\/p>\n Steketee, G., Frost, R., & Bogart, K. (1996). The Yale-Brown Obsessive Compulsive Scale: Interview versus self-report. Behaviour Research and Therapy<\/em>, 34(8), 675\u2013684. https:\/\/doi.org\/10.1016\/0005-7967(96)00036-8<\/a><\/p>\n2. Keywords<\/h2>\n
3. Authors<\/h2>\n
\n
4. Purpose<\/h2>\n
\n
5. Psychological Construct<\/h2>\n
The Obsessions Severity Domain (Items 1\u20135)<\/h3>\n
\n
The Compulsions Severity Domain (Items 6\u201310)<\/h3>\n
\n
6. Theoretical Framework<\/h2>\n
Cognitive-Behavioral Theory<\/h3>\n
Cortico-Striato-Thalamo-Cortical (CSTC) Circuit Dysregulation<\/h3>\n
7. Validity<\/h2>\n
Construct and Convergent Validity<\/h3>\n
Discriminant Validity<\/h3>\n
Treatment Sensitivity and Predictive Validity<\/h3>\n
8. Reliability<\/h2>\n
Internal Consistency<\/h3>\n
\n
Test-Retest Reliability and Stability<\/h3>\n
\n
9. Factor Analysis<\/h2>\n
Two-Factor Model (Obsessions vs. Compulsions)<\/h3>\n
\n
Alternative Three-Factor and Bifactor Models<\/h3>\n
\n
10. Instrument \/ Measurement Tool<\/h2>\n
\n
\n
\n
11. Permissions & Fee and Test Year<\/h2>\n
12. References<\/h2>\n